Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier

Bone Marrow Transplantation volume 29, pages 273–275 (2002)Cite this article

Abstract

The epidemiology and clinical outcome of multiple myeloma in human immunodeficiency virus (HIV)-positive patients is poorly documented. There are uncertainties concerning the optimal management of this rare disorder. We report on the use of myeloablative chemotherapy with autologous stem cell transplantation in an HIV-positive patient with multiple myeloma.

Bone Marrow Transplantation (2002) 29, 273–275. doi:10.1038/sj.bmt.1703348

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kaplan MH, Susin M, Pahwa SG et al. Neoplastic complications of HTLV-III infection Am J Med 1987 82: 389 396

    Article  CAS  Google Scholar 

  2. Kumar S, Kumar D, Schnadig VJ et al. Plasma cell myeloma in patients who are HIV-positive Am J Clin Pathol 1994 102: 633 639

    Article  CAS  Google Scholar 

  3. Grulich AE, Wan X, Law MG et al. Risk of cancer in people with AIDS AIDS 1999 13: 839 843

    Article  CAS  Google Scholar 

  4. Rabkin CS . Association of non-acquired immunodeficiency syndrome-defining cancers with human immunodeficiency virus infection Monogr Natl Cancer Inst 1998 23: 23 25

    Article  Google Scholar 

  5. Tirelli U, Vaccher E, Zagonel V et al. Malignant tumors other than lymphomas and Kaposi's sarcoma in association with HIV infection Cancer Detect Prevent 1988 12: 267 272

    CAS  PubMed  Google Scholar 

  6. Bladé J, Kyle RA . Multiple myeloma in young patients: clinical presentation and treatment approach Leuk Lymphoma 1998 30: 493 501

    Article  Google Scholar 

  7. Fiorino AS, Atac B . Paraproteinemia, plasmacytoma, myeloma and HIV infection Leukemia 1997 11: 2150 2156

    Article  CAS  Google Scholar 

  8. Herranz S, Sala M, Cervantes M et al. Neoplasia of plasma cells with atypical presentation and infection by the human immunodeficiency virus. A presentation of two cases Am J Hematol 2000 65: 239 242

    Article  CAS  Google Scholar 

  9. Heuberger L, Costello RT, Petit N et al. First case of plasma-cell leukemia co-existing with human immunodeficiency virus infection Leukemia 1998 12: 103 104

    Article  CAS  Google Scholar 

  10. Smith ML, Newland AC . Treatment of myeloma QJ Med 1999 92: 11 14

    Article  CAS  Google Scholar 

  11. Attal M, Harousseau JL, Stoppa A et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma New Engl J Med 1996 335: 91 97

    Article  CAS  Google Scholar 

  12. Gabarre J, Azar N, Autran B et al. High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1 associated lymphoma Lancet 2000 355: 1071 1072

    Article  CAS  Google Scholar 

  13. Molina A, Krishnan AY, Nadamanee A et al. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy Cancer 2000 89: 680 689

    Article  CAS  Google Scholar 

  14. Schneider E, Lambermont M, Van Vooren JP et al. Autologous stem cell infusion for acute myeloblastic leukemia in an HIV-1 carrier Bone Marrow Transplant 1997 20: 611 612

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinique d'Hématologie, ULB-Hôpital Erasme, Free University of Brussels, Brussels, Belgium

    A Kentos & W Feremans

  2. Unité de traitement des immunodéficiences, ULB-Hôpital Erasme, Free University of Brussels, Brussels, Belgium

    M Vekemans, JP Van Vooren & CM Farber

  3. Département d'Immunologie, Hématologie et Transfusion, ULB-Hôpital Erasme, Free University of Brussels, Brussels, Belgium

    M Lambermont

  4. Laboratoire de Virologie, ULB-Hôpital Erasme, Free University of Brussels, Brussels, Belgium

    C Liesnard

Authors
  1. A Kentos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Vekemans
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. JP Van Vooren
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Lambermont
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C Liesnard
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W Feremans
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. CM Farber
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kentos, A., Vekemans, M., Van Vooren, J. et al. High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier. Bone Marrow Transplant 29, 273–275 (2002). https://doi.org/10.1038/sj.bmt.1703348

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703348

Keywords

This article is cited by

Search

Advanced search

Quick links